arrow
A

Arturo Cesaro

university of campania luigi vanvitelli
H指数:32
被引数:3,358

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Visceral Adipose Tissue Measured by DXA, Prevalent Cardiovascular Disease, and Mortality in US Adults: Cross-Sectional and Prospective Analyses from NHANES 2011–2018

通过DXA测量的内脏脂肪组织、心血管疾病患病率及美国成年人死亡率:基于NHANES 2011–2018的横断面和前瞻性分析

2026-10-210
OAAI
“Lipoprotein(a) Across Coronary Plaque Phenotypes from High-Risk to Layered Plaque: An OCT Analysis from the RELACS Registry”

“脂蛋白(a)在从高危斑块到分层斑块的不同冠状动脉斑块表型中的分布:RELACS注册研究的光学相干断层扫描分析”

2026-09-030
PRE
Inflammatory biomarkers relationship with major adverse cardiovascular events and hypertensive-mediated organ damage, in subjects without established cardiovascular disease

炎症生物标志物与主要不良心血管事件及高血压介导的器官损害的关系,在无明确心血管疾病受试者中

2026-04-170
OAAI
Optimal Medical Therapy Targeting Metabolic Status for Secondary Prevention in Patients Undergoing Percutaneous Coronary Intervention
2026-01-310
OAAI
Optimal Medical Therapy Targeting Lipids and Inflammation for Secondary Prevention in Patients Undergoing Percutaneous Coronary Intervention

针对接受经皮冠状动脉介入治疗患者的二级预防,以脂质和炎症为目标的最佳药物治疗

2025-11-240
OAAI
Lung ultrasound in cardiac rehabilitation: expert consensus on protocols, clinical use, and integration into patient management from the working group on cardiac rehabilitation and cardiovascular prevention of the Italian society of cardiology

心脏康复中的肺超声:意大利心脏病学会心脏康复与心血管预防工作组关于方案、临床应用及融入患者管理的专家共识

2025-09-220
OAAI
Personalized or Standard Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: PARTHENOPE Randomized Trial

经皮冠状动脉介入治疗后个体化或标准双重抗血小板治疗持续时间:PARTHENOPE随机试验

JACC
IF0
2025-08-300
PRE
Reduction of new onset of atrial fibrillation in patients treated with semaglutide: an updated systematic review and meta regression analysis of randomized controlled trials

使用司美格鲁肽治疗患者中新发心房颤动风险的降低:一项更新的系统评价和随机对照试验的Meta回归分析

2025-04-281
PRE
Do Beta-Blockers Really Matter in Patients with Myocardial Infarction Without Left Ventricular Systolic Dysfunction? Comment on Sabina et al. Beta-Blockers in Patients with Myocardial Infarction and Preserved Left Ventricular Ejection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J. Clin. Med. 2025, 14, 150

β受体阻滞剂在无左心室收缩功能障碍的心肌梗死患者中真的重要吗?——关于Sabina等人关于β受体阻滞剂在心肌梗死且左心室射血分数保留患者中的研究:一项随机对照试验的系统评价和荟萃分析。J. Clin. Med. 2025, 14, 150

2025-03-260
OA